Objectives-To examine cerebral metabolism, cognitive performance, and brain volumes in healthy controls and two groups of patients with probable Alzheimer's disease, one group with severe abnormalities of white matter (DAT +) and the other group with none, or minimal abnormalities (DAT -). Methods-Neuropsychological tests, CT, MRI, quantitative MRI, and PET studies were carried out to allow comparison between the DAT + and DAT -groups and the healthy controls. Results-Compared with the healthy controls, both demented groups had significandy reduced global and regional cerebral metabolism, significant brain atrophy, and significantly lower scores on neuropsychological testing.
cerebral metabolism, significant brain atrophy, and significantly lower scores on neuropsychological testing.
The DAT -patient group showed a pattern of parietal-temporal cerebral metabolic reductions and neuropsychological performance deficits typical of Alzheimer's disease. In addition, metabolism in the association neocortex (AD ratio) and measures of neuropsychological task performance were significantly correlated in the DAT -patient group. Comparison of DAT + with DATpatients showed a significantly higher ratio of parietal to whole brain glucose utilisation for the DAT + group. Moreover, when comparing group z score differences from the healthy controls, the DAT + group had, on average, smaller differences from controls in the frontal, parietal, and temporal regions than did the DAT -group. Discriminant analysis using metabolic ratios of the frontal, parietal, and temporal regions showed cerebral metabolic patterns to be significantly different among the DAT +, the DAT-, and the healthy controls. These differences were due primarily to relatively higher frontal, parietal, and temporal metabolic ratios in the DAT + group which resulted in discriminant scores for the DAT well as no significant correlations between metabolism in the association neocortex and neuropsychological performance. These differences probably reflect the superimposed pathology of the abnormalities of white matter which may exert their affect through disruption of long corticocortical pathways.
Comparison ofpositron emission tomography, cognition ard brain volume in Alzheimer's disease with and without severe abnormalities of white matter to be more difficult. 
Methods

SUBJECTS
Healthy controls
The healthy control subjects consisted of seven men and seven women. Each subject underwent rigorous medical, neurological, and laboratory screening.30 Subjects with medical illness, psychiatric disorders, history of head trauma, or substance misuse were excluded. No subject received medication in the two weeks before the evaluation.
DAT-patients
The DAT -patient group consisted of eight men and six women selected with the same stringent health screening criteria as the hea-lthy controls. For each patient, Alzheimer's disease was diagnosed as "probable" using NINCDS-ADRDA criteria. 31 The degree of cognitive impairment was graded according to mini mental state examination (MMSE) scores32 as mild (MMSE > 20), moderate (> 10 MMSE < 20), and severe (MMSE < 10). The DAT -patients were chosen from a larger group and were selected to be comparable with the DAT+ group for age, education, severity of dementia, and duration of illness.
Five DAT-patients subsequently died. All met pathological criteria for definite Alzheimer's disease. 34 The presence of abnormalities of white matter was determined from either non-contrast CT, T2 weighted MRI, or both. Leukoaraiosis on non-contrast head CT was identified as present or absent by radiologists unaware of the clinical status of the subject and using the definition of Hachinski et al. 36 Leukoaraiosis of moderate to severe degree was present on CT To further examine regional metabolic differences between the DAT + and DATgroups, regional cerebral metabolism was converted into z score differences from healthy controls. To calculate each z score, the healthy control group mean rCMRglc was subtracted from each patient's rCMRglc and divided by the healthy control group rCMRglc SD. Figure 2 shows the mean z score differences from controls in rCMRglc/CMRglc. The DAT-group shows the typical frontal, tem- poral, parietal pattern of hypometabolism thought to be characteristic of Alzheimer's disease, whereas the DAT + group shows a relative sparing of metabolism in these areas. Given these between group differences, discriminant analysis was performed using the frontal, parietal, and temporal metabolic ratios (listed as RPREF to LSUPTMP in fig 2) . We chose discriminant analysis as this statistical method allows for estimation of the linear combination of all the regions on group differences. We also included the healthy control group in this analysis to show how the two dementia groups differ, not only from each other, but in relation to subjects without dementia (are the two dementia groups different because one group looks more like the healthy controls, or is the pattern of cerebral metabolism uniquely different among each of the dementia groups and controls?). Because the discriminant analysis was performed between three groups, two discriminant functions are generated and subject classification is based on a weighted combination of the scores along each function. Subject classification based on the combined information of the two discriminant functions was significant (Wilks' lambda = 0-24, F(24,48) = 2 06, P = 0-017) and completely accurate for all groups. That is, each subject used to derive the discriminant function was correctly classified as DAT +, DAT -, or healthy control.
The first discriminant function explained 81% of the between group differences (P < 0 02). Individual discriminant scores correlated significantly (P < 0-01) with the right and left frontal premotor, right and left superior and inferior parietal, and right and left middle temporal metabolic ratios, regions preferentially involved in Alzheimer's disease.'I4 4 The group discriminant score means were 1 57 (SD 0 85) for the healthy controls, -0 17 (SD 0 97) for the DAT + patients, and -1 55 (1 55) for the DAT-patients. Analysis of variance showed a significant group effect of discriminant scores (F(2,3, = 33, P < 0-0001). On post hoc analysis, each group was significantly different from the others. The DAT + patients, therefore, had a significantly different pattern of glucose utilisation with generally higher metabolic ratios than the DAT-patients, but generally lower metabolic ratios than the healthy controls.
The second discriminant function explained the remaining variance, but was not significant (F(, 25) = 0 98, P = 0 49). The group discriminant score means along this function, however, were 0-34 (SD 0 86) for the healthy controls, 0 46 (SD 1 17) for the DAT- Patterns of cerebral metabolism have been 4 (126) 820 (20) 8849 (28) (15) metabolism and cognitive performance in 3 (382) 11-0 (7-0) 11-3 (6-1) healthy subjects,6 we would expect their pres-0(380) 368 (49) 270 (14)* ence to have a similar effect in the DAT + 2 (2-1) 6-4 (45) 5.6 (53) patients. Using the metabolic ratio (AD ratio)
4 8-5 (6-4) 3-7 (4-3)
described by Mielke et a1,53 we examined the 40) 137 (103) 437 (130) relation between cerebral glucose metabolism and severity of dementia for the DAT-and p means for each nuropsychological score differed DAT+ groups. The mean AD ratio scores were 0 83 (SD 0 13) for the DAT-group and 0-86 (SD 0 l0) for the DAT+ group. Table 4 and -0-98 (SD 0 95) for the DAT + shows the zero order correlations between the AD ratio and various scales of the WAIS and iination of the biterritorial map of stan-the MMSE. )res on the first and second discrimiSignificant and large correlations between ictions (fig 3) disclosed three distinct the AD ratio and four of the scale scores of the consistent with a unique metabolic WAIS and the MMSE were found for the for each group. The healthy controls DAT-patients, whereas no relation was sigi in the positive range of the first func-nificant for the DAT + patients. As small t near zero in the second function. The group size and high variance could have congroup clustered in the negative range tributed to the lack of significant correlations irst function and along the entire axis between the AD ratio and neuropsychological second function. The DAT + group, test scores in the DAT + group, we performed clustered near zero on the first func-a multiregression analysis of the relation negatively on the second function in between the neuropsychological test scores not occupied by either the controls or and AD ratio to assess whether this relation groups.
was the same for the two demented groups. All ise the discriminant analysis was per-multiple regression models were statistically on many regions, we also examined significant (P < 0 05). In three models where egions had the greatest independent MMSE, WAIS verbal deviation quotient i the group differences by using step-(WVDQ), and WAIS memory and freedom ;crimination. Nearly all the between from distractability deviation quotient ifferences were explained by four vari-(WMDQ) were used to predict the AD ratio, The left inferior parietal region the group effect was significant. In three other d 20% of the variance, the right models where WAIS full scale IQ (WFSIQ), remotor region 30%, the left superior WAIS verbal IQ (WVIQ), and WAIS perfor- between central CSF volumes and MMSE for the demented patients (r = -049, P < 0 03) which did not differ significantly between the DAT-group (r = -0 37) and the DAT+ group (r = -0-54). Between group differences in the number of MRIs quantified did not seem to bias the results as there was neither a significant difference in the number of missing scans between the DAT-and DAT+ groups (X2 = 0-9, P > 0-05), nor a significant difference in the MMSE of the patients having MRI (DAT-mean MMSE = 13 5 (SD 8-6); DAT+ mean MMSE = 9-6 (SD 9-1); P > 005).
mance deviation quotient (WPDQ) were used to predict the AD ratio, the group effect showed a trend toward significance with P values < 0-10. Moreover, in the model, when WMDQ was used to predict the AD ratio, the interaction term between group and WMDQ was significant, and in three other models, where WVDQ, WVIQ, and MMSE were used as predictors the interaction term had a P value < 0-11. Figure 4 shows the relation between AD ratios and WMDQ scores. The AD ratio was greater for the DAT + group (significant group effect, F(1,24) = 7 4, P < 0 5), and the slopes of group regression lines were significantly different (significant interaction, F(1,24) = 5-2, p < 005), indicating a different relation between the AD ratio and WMDQ scores.
Age, years of education, and sex are also known to influence performance on neuropsychological tasks in healthy subjects.56 As between group differences on these variables could have influenced analysis of neuropsychological test scores between the DAT + and DAT -groups, we examined the predictive value of these variables on each neuropsychological task. None significantly predicted performance on any neuropsychological task.
QUANTITATIVE MRI
The two dementia groups had significantly smaller total brain and cerebral hemisphere volumes and significantly larger central and subarachnoid CSF volumes than healthy controls (P < 0O01). Table 5 summarises the brain and CSF volumes for the DAT -and DAT + groups. No significant between group difference was found in either brain matter or CSF volumes. There was a significant correlation Right hemisphere brain volume ( 1 7) 40-4 (3-1) 40 teristics specific to these abnormalities, it could be that subtle neuropsychological differences are present when the dementia is mild, but are overwhelmed by the Alzheimer's disease process as the dementia progresses. Significant group differences in neuropsychological scores related to the presence of abnormalities of white matter, therefore, may not have been seen due to the moderate to severe degree of cognitive impairment in our patients. Small group size could have also limited our results. Consistent with previous data,'8 the DAT + patients had generally lower neuropsychological test scores than the DAT-patients. Larger sample sizes would have given us the statistical power necessary to more accurately ascertain whether these differences were truly significant under the conditions tested.
We were, however, most interested in the relation between neuropsychological performance and cerebral metabolism among the DAT -and DAT + groups. The pattern of neocortical glucose metabolism was significantly different between the two dementia groups; however, as noted, both groups had a generally equal degree of dementia severity. This suggests that dysfunction of different brain regions may underlie the cognitive deficits among the two groups. Previous reports'4 52 53 have shown significant relations between cerebral metabolism in the association neocortices and numerous neuropsychological tasks in patients with Alzheimer's disease. Using the AD ratio reported by Mielke et al,53 we duplicated the previously reported significant correlation between neuropsychological performance and metabolism for the DAT -group, but not the DAT + group. Multivariate analyses of the relation between the AD ratio and neuropsychological test scores for the two dementia groups also showed significant between group differences on one neuropsychological task, and a trend toward significance for three others which was not explained by the confounding effects of age, sex, and education. Although the interaction was significant only on one neuropsychological measure, this particular task reflects memory and attentional processes which have been previously shown to be affected in healthy subjects with abnormalities of white matter.46 Given the trend toward significance in three additional cognitive tasks, larger patient groups might have disclosed more generalised differences in the relation between neocortical metabolism and neuropsychological tests.
Wallerian degeneration of cortical neurons caused by Alzheimer's disease has been one hypothesis proposed to explain the increased prevalence of abnormalities of white matter in patients with Alzheimer's disease. 60 If neuronal cell death and subsequent Wallerian degeneration of axons was the sole cause of abnormalities of white matter in Alzheimer's disease, we would expect to see greater cerebral atrophy in the DAT + group when compared by dementia severity. Or, if not mean differences in cerebral volume, differences in the relation between severity of dementia and cerebral volume in patients with DAT+. We found neither. Not only were the group mean volumes nearly identical, but the relation between cerebral volume and severity of dementia was the same for both groups. Non-demented subjects with abnormalities of white matter have significantly greater cerebral atrophy, however, suggesting that these abnormalities are associated with tissue loss.6-9 The volume of tissue loss associated with abnormalities of white matter, although significant, is relatively small (about 3 0% in one study6). Tissue loss caused by Alzheimer's disease is greater than the tissue loss due to abnormalities of white matter,'5 and may therefore obscure group differences in brain volume caused by abnormalities of white matter in the DAT + group.
Our data, however, do mitigate against the notion that abnormalities of white matter are the inevitable consequence of Alzheimer's disease. Members of both the DAT + and DAT -groups spanned the entire range of severity of dementia, including patients with minimal to severe cerebral atrophy. In addition, five members of each dementia group have had pathological confirmation of Alzheimer's disease. Detailed analysis of cerebral vasculature, white matter, and grey matter in a subset of these patients6' showed the presence of severe cerebral amyloid angiopathy, myelin pallor, and astrocytosis without axon loss in the DAT + group, which was absent from the DAT -patients. These data suggest that a pathology additional to, or coincident with, the markers of Alzheimer's disease,3435 such as cerebral amyloid angiopathy, or other processes known to cause abnormalities of white matter, such as hypertensive vasculopathy,l are present in patients with Alzheimer's disease with severe abnormalities of white matter. How abnormalities of white matter might affect cerebral metabolism and cognition was not considered in our study. One hypothesis proposes that abnormalities of white matter affect cerebral metabolism through impairment of long corticocortical neurons leading to a functional "disconnection".6626' Healthy subjects with large hyperintense lesions in white matter show significant reductions in frontal lobe glucose utilisation which has been attributed to damage to corticocortical axons passing through central cerebral white matter.6 A similar process could explain the metabolic pattern of the DAT + patients, in whom the prototypical temporal-parietal dysfunction of Alzheimer's disease is diminished, and a more generalised reduction of cerebral metabolism is seen instead.662 Dysfunction in brain regions outside the temporal and the parietal lobes, particularly in the frontal lobe,4 might contribute to the cognitive impairment seen in the DAT+ patient group, and is consistent with the clinical findings of less pronounced parietal lobe dysfunction in patients with Alzheimer's disease with abnormalities of white matter. 20 Although the aetiology may be diverse (for example, aging, cerebral amyloid angiopathy, or hypertension), the presence of severe abnormalities of white matter in patients with dementia affects the pattern of cerebral metabolism of glucose and the relation between the Alzheimer's disease ratio and WMDQ scores. In this regard, DAT + patients seem to be a subgroup of Alzheimer's disease wherein abnormalities of white matter indicate another concurrent pathological process. The clinical and research implications are unclear at this time, but further studies might elucidate these differences. 
